NOS3 Polymorphisms and Chronic Kidney Disease

• Main Author: Medina,Alejandro Marín
• Publication Date: 2018
• Other Authors: Zubero,Eduardo Esteban, Jiménez,Moisés Alejandro Alatorre, Barragan,Sara Anabel Alonso, García,Carlos Arturo López, Ramos,José Juan Gómez, Gutierrez,Juan Francisco Santoscoy, Castillo,Zurisadai González
• Format: Article
• Language: eng
• Source: Jornal Brasileiro de Nefrologia
• Download full: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002018000300273
• topic: Renal Insufficiency, Chronic; Nitric Oxide Synthase; Polymorphism, Genetic

ABSTRACT Chronic kidney disease (CKD) is a multifactorial pathophysiologic irreversible process that often leads to a terminal state in which the patient requires renal replacement therapy. Most cases of CKD are due to chronic-degenerative diseases and endothelial dysfunction is one of the factors that contribute to its pathophysiology. One of the most important mechanisms for proper functioning of the endothelium is the regulation of the synthesis of nitric oxide. This compound is synthesized by the enzyme nitric oxide synthase, which has 3 isoforms. Polymorphisms in the NOS3 gene have been implicated as factors that alter the homeostasis of this mechanism. The Glu298Asp polymorphisms 4 b/a and -786T>C of the NOS3 gene have been associated with a more rapid deterioration of kidney function in patients with CKD. These polymorphisms have been evaluated in patients with CKD of determined and undetermined etiology and related to a more rapid deterioration of kidney function.